Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

November 29, 2019

Primary Completion Date

January 3, 2021

Study Completion Date

April 15, 2021

Conditions
Maintenance HemodialysisHyperphosphatemia
Interventions
DRUG

Phosphate-binder intervention

Use phosphate-binders according to KDIGO Guidelines, Chinese Guidance for Diagnosis and Treatment of Mineral and Bone Disorder in Chronic Kidney Disease and drug specification .

DIETARY_SUPPLEMENT

Phosphorus-restricted dietary intervention

Use low phosphorus diet and prolong the time of hemodialysis according to the phosphorus balance evaluation if necessary

Trial Locations (2)

200000

Huadong Hospital, Fudan University, Shanghai

Tongji Hospital, Tongji University, Shanghai

All Listed Sponsors
collaborator

Huadong Hospital

OTHER

collaborator

Shanghai Tongji Hospital, Tongji University School of Medicine

OTHER

lead

Chen Jing

OTHER

NCT03861247 - Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients | Biotech Hunter | Biotech Hunter